8-K: Marpai Inc. Secures $150,000 in Private Placement, CEO's Entity Invests Heavily

Marpai Inc. completed a private placement of 130,208 shares of Class A common stock at $1.152 per share, raising approximately $150,000, with a significant portion purchased by an entity controlled by its Chief Executive Officer.

Summary

• Marpai Inc. entered into a Securities Purchase Agreement on July 17, 2024, for a private placement of its Class A common stock.
• The company issued and sold an aggregate of 130,208 shares of Class A common stock at a purchase price of $1.152 per share.
• The total capital raised from this private placement is approximately $150,000.
• One of the two investors, HillCour Investment Fund, LLC, which is controlled by Marpai's Chief Executive Officer, Damien Lamendola, purchased 86,805 shares of the common stock.
• The securities issued are exempt from registration requirements under Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506(b) of Regulation D.
• The shares are restricted securities and have not been registered under the Securities Act.

Sentiment

Score: 5

Explanation: The capital raise provides some liquidity but is relatively small. The involvement of the CEO's entity is a mixed signal, showing confidence but also potential reliance on insider funding. No major positive or negative operational news is presented.

Positives

• Secured approximately $150,000 in capital through a private placement, providing additional funding for the company.
• The participation of the CEO's controlled entity, HillCour Investment Fund, LLC, in the private placement demonstrates management's continued investment and confidence in the company.

Negatives

• The capital raise of approximately $150,000 is relatively small, which may indicate limited funding options or a short-term liquidity solution rather than significant growth capital.
• The involvement of an entity controlled by the CEO (HillCour Investment Fund, LLC) in the private placement could raise questions about potential conflicts of interest or the fairness of the terms for other shareholders, especially given the non-registered nature of the offering.
• The issuance of new shares will result in dilution for existing shareholders.

Risks

• Dilution: The issuance of 130,208 new shares of Class A common stock will dilute the ownership percentage of existing shareholders.
• Liquidity Risk: The relatively small amount of capital raised ($150,000) might not be sufficient to address long-term financial needs or significant operational challenges, potentially leading to further capital raises in the near future.
• Related Party Transaction Scrutiny: The involvement of an entity controlled by the CEO in the private placement could lead to increased scrutiny from investors and regulators regarding the terms and fairness of the transaction.
• Unregistered Securities: The securities were issued under an exemption from registration, meaning they are restricted and cannot be freely traded without registration or an applicable exemption (e.g., Rule 144), which could affect their liquidity for the purchasers.
• Market Conditions: The agreement includes conditions for closing related to the suspension of trading in common stock or general securities, or a banking moratorium, which could prevent the transaction from closing.

Future Outlook

The document does not provide explicit forward-looking statements or guidance regarding future financial performance, strategic initiatives, or operational targets. It focuses solely on the completed private placement transaction.

Management Comments

• Marpai Inc. completed a private placement of 130,208 shares of Class A common stock at $1.152 per share, with a significant portion purchased by HillCour Investment Fund, LLC, an entity controlled by CEO Damien Lamendola.

Industry Context

This private placement is a common method for smaller public companies to raise capital quickly, especially when traditional public offerings might be less feasible or more costly. The participation of a CEO-controlled entity is not uncommon in such scenarios, often signaling insider confidence, but can also raise governance questions. The health technology or third-party administrator (TPA) industry, in which Marpai operates, often requires ongoing capital for technology development, market expansion, and operational scaling.

Comparison to Industry Standards

• The per-share purchase price of $1.152 for a private placement is specific to Marpai's current valuation and market conditions. Without comparable private placement data from similar-sized health tech or TPA companies at the same time, a direct comparison of the pricing is difficult.
• The total capital raised of $150,000 is a relatively small amount for a public company, especially in the health tech sector where significant capital is often required for innovation and growth. Larger, more established health tech companies like Teladoc Health (TDOC) or Livongo (acquired by TDOC) typically raise hundreds of millions or billions in public offerings or venture rounds.
• The involvement of a CEO-controlled entity in a private placement is a common practice across various industries for companies seeking capital, but the proportion of the raise coming from the related party (approximately 66.7% of the shares) is substantial, indicating a strong reliance on insider funding for this particular raise.

Corporate Governance

Related Party Transactions

• HillCour Investment Fund, LLC, an entity controlled by Marpai Inc.'s Chief Executive Officer, Damien Lamendola, purchased 86,805 shares of Class A common stock in the private placement.

Stakeholder Impact

• Shareholders: Experience dilution due to the issuance of new shares. The participation of the CEO's entity might be viewed positively as a sign of confidence or negatively as a potential governance concern.
• Company (Marpai Inc.): Receives approximately $150,000 in capital, which can be used for general corporate purposes, improving liquidity.
• Investors (Purchasers): Acquire restricted shares at a fixed price, subject to transfer limitations, but potentially as a strategic investment.

Next Steps

• The company will timely file a Form D with respect to the Securities as required under Regulation D.
• The company will take necessary action to obtain an exemption for, or to qualify the Securities for, sale under applicable state securities or Blue Sky laws.

Key Dates

Recommendation

Keywords

Marpai Inc., MRAI, Private Placement, Equity Raise, Securities Purchase Agreement, Class A Common Stock, HillCour Investment Fund, Damien Lamendola, CEO, Unregistered Securities, Form 8-K, Capital Raise, Dilution, Related Party Transaction